Sandbox Epi: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Created page with "===Prevalence=== * In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in (insert year here). ===Incidence=== * The delay-adjusted ..." |
Rim Halaby (talk | contribs) No edit summary |
||
Line 54: | Line 54: | ||
** Type Y: _____ % | ** Type Y: _____ % | ||
** Type Z: _____ % | ** Type Z: _____ % | ||
------ | |||
===5 Year Survival==== | |||
* Between (insert age here) and (insert age here), the 5 year relative survival of patients with (insert disease name here) was _____ %. | |||
* When stratified by age, the 5 year relative survival of patients with (insert disease name here) was ____ % and ____ % for patients <65 and ≥ 65 years of age respectively. | |||
* The survival of patients with (insert disease name here) varies with the stage of the disease. Shown below is a table depicting the 5 year relative survival by the stage of (insert disease name here): | |||
{| style="cellpadding=0; cellspacing= 0; width: 600px;" | |||
|- | |||
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Stage'''|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | '''5 year relative survival (%), (Insert range of years here)''' | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |All stages|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |Localized|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |Regional|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |Distant|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | | |||
|- | |||
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |Unstaged|| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | | |||
|} | |||
Shown below is an image depicting 5 year conditional relative survival (probability of surviving in the next 5 years given the cohort has already survived 0, 1, 3 years) by stage at diagnosis according to SEER. | |||
[Insert figure x.5 here] |
Revision as of 13:24, 11 June 2014
Prevalence
- In the United States, the [age adjusted] prevalence of (insert disease name here) is _____ % in (insert year here).
Incidence
- The delay-adjusted incidence of (insert disease name here) in (insert year here) was estimated to be _____ per 100,000 persons in the United States.
- In (insert year here), the age-adjusted incidence of (insert disease name here) was _____ per 100,000 persons in the United States.
Age
- While the overall age adjusted incidence of (insert disease name here) in the United States between (insert year here) and (insert year here) is _____ per 100,000, the age-adjusted incidence of (insert disease state here) by age category is:
- Under 65 years: _____ per 100,000
- 65 and over: _____ per 100,000
Gender
- In the United States, the [age adjusted] prevalence of (insert disease state here) by gender in (insert year here) is:
- In females: _____ %
- In males: _____ %
- In the United States, the delay-adjusted incidence of (insert disease state here) by gender in (insert year here) is:
- In females: _____ per 100,000 persons
- In males: _____ per 100,000 persons
- In the United States, the age-adjusted incidence of (insert disease state here) by gender on (insert year here) is:
- In females: _____ per 100,000 persons
- In males: _____ per 100,000 persons
Shown below is an image depicting the delay-adjusted incidence of (insert disease name here) by gender and race in the United States between (insert year range here).
[Insert figure x.1 from the report]
Race
- In the United States, the [age adjusted] prevalence of (insert disease state here) by race in (insert year here) is:
- In all races: _____ %
- In white: _____ %
- In black: _____ %
- In Asian/pacific islander: _____ %
- In Hispanic: _____ %
- In the United States, the race that is most susceptible to developing this disease/condition, is the ____ race.
Shown below is an image depicting the incidence of (insert disease name here) by race in the United States between (insert year range here).
[Insert figure x.2 from the report]
Percent Distribution of (insert disease name here) by Histology
- Among patients with histologically confirmed cases of (insert disease name here), the percent distribution of the types of the disease between 2004 and 2010 in the United States are:
- Type X: _____ %
- Type Y: _____ %
- Type Z: _____ %
5 Year Survival=
- Between (insert age here) and (insert age here), the 5 year relative survival of patients with (insert disease name here) was _____ %.
- When stratified by age, the 5 year relative survival of patients with (insert disease name here) was ____ % and ____ % for patients <65 and ≥ 65 years of age respectively.
- The survival of patients with (insert disease name here) varies with the stage of the disease. Shown below is a table depicting the 5 year relative survival by the stage of (insert disease name here):
Stage | 5 year relative survival (%), (Insert range of years here) |
All stages | |
Localized | |
Regional | |
Distant | |
Unstaged |
Shown below is an image depicting 5 year conditional relative survival (probability of surviving in the next 5 years given the cohort has already survived 0, 1, 3 years) by stage at diagnosis according to SEER.
[Insert figure x.5 here]